Edralbrutinib
Edralbrutinib (TG-1701) is a potent and selective BTK inhibitor used in research for oncology and autoimmune disorders. Its applications include studies in B-cell malignancies, membranous nephropathy, and neuromyelitis optica, supported by in vitro and in vivo experimental data.
Product Specifications
CAS Number
1858206-58-2
Product Name Alternative
BTK, Edralbrutinib, TG 1701, TG1701, TG-1701
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.84% (May vary between batches)
Solubility
DMSO:55 mg/mL (112.37 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.04 mM)
Smiles
O=C1C2=C (C (=CN2[C@H]3CN (C (C#CC) =O) CC3) C4=CC=C (OC5=C (F) C=CC=C5F) C=C4) C (N) =NN1
Molecular Formula
C26H21F2N5O3
Molecular Weight
489.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog